Abstract
Corticosteroid therapy is recommended for initial treatment for cardiac sarcoidosis (CS). However, optimal maintenance dose and evaluation method for activity of CS are not established. We evaluated the activity of CS by 18F-fluorodeoxyglucose PET (FDG) during maintenance dose period of
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
